HPV infections: Can they be eradicated using nanotechnology?

Abstract Human papillomavirus (HPV) infections are considered the most common sexually transmitted diseases, with more than 450 million people worldwide infected. HPVs can cause anogenital warts and neoplasias. One prevalent cancer type caused by HPV (mostly type 16 and 18) is cervical intraepitheli...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nanomedicine 2012-02, Vol.8 (2), p.131-135
1. Verfasser:	Foldvari, Marianna, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Topical Cervical cancer Cervical Intraepithelial Neoplasia - epidemiology Cervical Intraepithelial Neoplasia - prevention & control Cervical Intraepithelial Neoplasia - virology Drug Delivery Systems Human papillomavirus Human papillomavirus 16 - pathogenicity Human papillomavirus 18 - pathogenicity Humans Interferon-alpha - metabolism Internal Medicine Nanoparticles - therapeutic use Nanotechnology Nanotechnology - methods Papillomavirus Vaccines - therapeutic use Topical interferon alpha Vaccine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Abstract Human papillomavirus (HPV) infections are considered the most common sexually transmitted diseases, with more than 450 million people worldwide infected. HPVs can cause anogenital warts and neoplasias. One prevalent cancer type caused by HPV (mostly type 16 and 18) is cervical intraepithelial neoplasia (CIN). Nanotechnology tools employed in the development of vaccines and a noninvasive treatment may provide a significant advancement in the global combat against this disease.
ISSN:	1549-9634 1549-9642
DOI:	10.1016/j.nano.2011.11.006